Department of Otorhinolaryngology-Head and Neck Surgery, Mie University Graduate School of Medicine, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
J Neuroinflammation. 2018 Apr 26;15(1):124. doi: 10.1186/s12974-018-1168-7.
Refractory olfactory dysfunction is a common finding in head trauma due to olfactory nerve injury. Anti-inflammatory treatment using steroids is known to contribute to functional recovery of the central and peripheral nervous systems in injury models, while there is a concern that steroids can induce side effects. The present study examines if the inhibition of proinflammatory cytokine, high mobility group box 1 (HMGB1), can facilitate olfactory functional recovery following injury.
Olfactory nerve transection (NTx) was performed in OMP-tau-lacZ mice to establish injury models. We measured HMGB1 gene expression in the olfactory bulb using semi-quantitative polymerase chain reaction (PCR) assays and examined HMGB1 protein localization in the olfactory bulb using immunohistochemical staining. Anti-HMGB1 antibody was intraperitoneally injected immediately after the NTx and histological assessment of recovery within the olfactory bulb was performed at 5, 14, 42, and 100 days after the drug injection. X-gal staining labeled OMP in the degenerating and regenerating olfactory nerve fibers, and immunohistochemical staining detected the presence of reactive astrocytes and macrophages/microglia. Olfactory function was assessed using both an olfactory avoidance behavioral test and evoked potential recording.
HMGB1 gene and protein were significantly expressed in the olfactory bulb 12 h after NTx. Anti-HMGB1 antibody-injected mice showed significantly smaller areas of injury-associated tissue, fewer astrocytes and macrophages/microglia and an increase in regenerating nerve fibers. Both an olfactory avoidance behavioral test and evoked potential recordings showed improved functional recovery in the anti-HMGB1 antibody-injected mice.
These findings suggest that inhibition of HMGB1 could provide a new therapeutic strategy for the treatment of olfactory dysfunction following head injuries.
由于嗅神经损伤,创伤性头部损伤后常出现难治性嗅觉功能障碍。已知使用类固醇的抗炎治疗有助于损伤模型中中枢和外周神经系统的功能恢复,而人们担心类固醇会引起副作用。本研究检查了抑制促炎细胞因子高迁移率族蛋白 1(HMGB1)是否可以促进损伤后的嗅觉功能恢复。
在 OMP-tau-lacZ 小鼠中进行嗅神经横断术(NTx)以建立损伤模型。我们使用半定量聚合酶链反应(PCR)检测嗅球中 HMGB1 基因的表达,并使用免疫组织化学染色检测嗅球中 HMGB1 蛋白的定位。在 NTx 后立即经腹腔注射抗-HMGB1 抗体,并在药物注射后 5、14、42 和 100 天对嗅球内的恢复进行组织学评估。X-gal 染色标记退变和再生嗅神经纤维中的 OMP,免疫组织化学染色检测反应性星形胶质细胞和巨噬细胞/小胶质细胞的存在。使用嗅觉回避行为测试和诱发电位记录评估嗅觉功能。
HMGB1 基因和蛋白在 NTx 后 12 小时在嗅球中明显表达。抗-HMGB1 抗体注射小鼠显示损伤相关组织的面积明显较小,星形胶质细胞和巨噬细胞/小胶质细胞较少,再生神经纤维增加。嗅觉回避行为测试和诱发电位记录均显示抗-HMGB1 抗体注射小鼠的功能恢复得到改善。
这些发现表明,抑制 HMGB1 可能为治疗头部损伤后嗅觉功能障碍提供一种新的治疗策略。